Olutasidenib, CAS [[1887014-12-1]]

Produktübersicht

• Artikelname: Olutasidenib, CAS [[1887014-12-1]]
• Artikelnummer: MCE-HY-114226
• Hersteller Artikelnummer: HY-114226
• Alternativnummer: MCE-HY-114226-10MG,MCE-HY-114226-50MG,MCE-HY-114226-10MMX1ML,MCE-HY-114226-5MG,MCE-HY-114226-100MG,MCE-HY-114226-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: FT-2102

Produktbeschreibung

Olutasidenib (FT-2102) is a highly potent, orally active, brain penetrant and selective inhibitor of mutant Isocitrate dehydrogenase 1 (IDH1), with IC50 values of 21.2 nM and 114 nM for IDH1- R132H and IDH1- R132C, respectively . Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) [1][2].

Produkteigenschaften

• Molekulargewicht: 354.79
• Reinheit: 99.16
• CAS Nummer: [1887014-12-1]
• Formel: C18H15ClN4O2
• Target-Kategorie: Isocitrate Dehydrogenase (IDH)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound